RSS feedFrederik Cyrus Roeder
Frederik Roeder is a German health economist. He studied hospital management, health economics and international business at the universities of Goettingen (Germany), Bayreuth (Germany), Maribor (Slovenia), and Tongji Shanghai (China). He has worked as a Visiting Professor for Health Economics at the Lithuanian University of Health Sciences and as a Visiting Professor for Healthcare Management and Economics at Ilia State University (Georgia). Fred Roeder is the Managing Director of Healthcare Solutions, a service focused on know-how transfer and policy advise for healthcare systems in transition.
Michael Schlander
Professor Michael Schlander MD, PhD, MBA is a health economist at the University of Heidelberg and a professor of health care and innovation management at the University of Applied Economic Sciences, Ludwigshafen. He is the founder and scientific director of the Institute for Innovation and Valuation in Health Care (Inno Val HC) a not for profit institute based in Eschborn, Germany. Professor Schlander who is also a physician has written ground-breaking studies on the role and limits of current evaluation methodology in adminstrative assessments of medical innovation.
Nicoleta Acatrinei
Graduate in economics and in theology, Nicoleta is currently preparing a PhD at the Swiss Federal Polytechnicum (ETH) in Zurich. She has spoken and written on topics related to ethics, economy and theology in Switzerland, China, Denmark and others. She is the author of "St Jean Chrysostome et l'Homo Oeconomicus" a scholarly work that explores the theological roots of market ethics. She has joined Medicine & Liberty in 2009 as our research fellow in charge of Ethics in Economics.
Francis Thevoz
Dr Francis Thevoz is a Cardiovascular surgeon by training. Past-president of the Société Vaudoise de Médecine he is also a former councilor of the City of Lausanne where he served as Director of finances. He is currently a member of the finance commision of the city's parliament. Francis will notably participate in the development of MedLib's, Privamed-Pro project.
Sophie Crespo
Sophie Crespo MD, our special projects & editorial consultant based in Geneva, graduated from Basel University Medical School. She holds specialist titles in intern al medicine and anesthesiology.
Contact: sophiecrespomd@medlib.ch
Fabienne Gay-Crosier
Dr Fabienne Gay-Crosier, joined MedLib's Medical Advisory Council in 2014. She is past president of the professional policy commisssion at the Swiss Society of Clinical Allergology and Immunology and is a firm advocate of professional independence for physicians. Author of "Geneva's White Paper on Allergy" Fillon Impr. Oct. 2015.
Loredana D'Amato Sizonenko MD
Dr D'Amato Sizonenko is a geneticist specialized in rare diseases. She is presently Coordinator for Switzerland of Orphanet, an international database of information on rare diseases and orphan drugs for all publics, designed to contribute to the improvement of the diagnosis, care and treatment of patients with rare diseases.
Martín Krause
Martin Krause is the diirector of the Centro de Investigations de instituciones y Mercados de Argentina: professor of Economics at the University of Buenos Aires.
Philip Stevens
Philip Stevens, Director of Policy at International Policy Network, London is the author of numerous health policy publications, including Fighting the diseases of Poverty (2007), Free trade for better health (2006) and The 10/90 Gap and the diseases of poverty (2004). He has also held research positions at the Adam Smith Institute and Reform in London and holds degrees from the London School of Economics and Durham University.
Shahnaz Radjy
After graduating in Biology at UPenn in Philadelphia, Ms Shahnaz Radjy was active in humanitarian action in Bolivian hospitals, and founded an A-TIC internet venture in Bolivia. She has also organized events for the International Labor Organization in Geneva and worked for the Davos World Economic Forum. Shahnaz is now based in NY and works as senior communications specialist for Vitality.
Bart Madden
Bartley Madden is an independent researcher who has developed "Dual Tracking": a fast lane for access to experimetal medicines, that also introduces an open database on new therapies. Bart Maddens concept is supported by Vernon Smith, Nobel prize in economics 2002 and by other reputed US economists. He has authored a monograph: "Dual Tracking, More Choices Better Health" edited by the Heartland Institute, Chicago.
Stefan Metzeler
Graduate from the Ecole Polytechnique Fédéerale de Lausanne (EPFL). Information and technology specialist, owner at Amadeus IT solutions. Swiss representative fo the International Society for Individual Liberty ISIL.
Contact: smetzeler@medlib.ch
Pierre Bessard
Executive Director of the Institut Constant de Rebecque, Lausanne, and President of the Liberales Institut, Zurich
Henri Siegenthaler
President of the Swiss Society for the Independence of medicine and editor in chief of « Der Arzt und sein Patient / Le Médecin et son Patient » Journal. Author of "Serons nous tous euthanasiés?" Ed.Cabedita (2015).
Pierre Lemieux
Professor of economics at the University of Québec in Outaouais. Author of "Le Droit de porter des armes"(1993), "Comprendre l'économie (2008) and other works such as "Public Health Insurance under a Non Benevolent State". Editor of Liberty in Canada online tribune.
Georges Lane
Georges Lane is a Professor of economics at the University of Paris-Dauphine where he teaches insurance economics.
Philip Stevens
Philip Stevens, Director of Policy
Philip is the author of numerous health policy publications, including Fighting the diseases of Poverty (2007), Free trade for better health (2006) and The 10/90 Gap and the diseases of poverty (2004). His writings on health policy have appeared in a wide range of international newspapers. Philip has also held research positions at the Adam Smith Institute and Reform in London, and spent several years as a management consultant. He holds degrees from the London School of Economics and Durham University.
Ernest Truffer
Swiss ENT surgeon and medical philosopher. One of the founding members of IATROS, a world organization of private and independent physicians. Writes regularly on medical ethics and other issues in various medical journals and in his blog.
Ernest unfortunately passed away on March 11th, 2015 and wil be deeply regretted by all those who knew him. The founding principles of Medicine and Liberty were strongly influenced by his profound understanding of the medical mission and his uncompromising attachment to Hippocratic ethics.
Gabriel Calzada
Professor of economics at the Universidad Rey Juan Carlos, Madrid. Founder of Medicina en Libertad (MedLib.es) and of Madrid's Instituto Juan de Mariana.
Gabriel is president of Francisco Marroquin University in Guatemala and member of the presidential board of the prestigious Mont Pelerin Society
Victoria Curzon Price
Professor of economics at the University of Geneva. President of Institut Constant de Rebecque, Lausanne. Member of Geneva Parlliament. Past president of the Mont Pelerin Society.
Rudolf Mayer
A practicing Opthalmologist in Lausanne. Active in Swiss medical professional politics he is a staunch defender of medical autonomy. He is on the editorial board of the Swiss medical journal "Arzt un Patient" (Physician and Patient)
Alphonse Crespo
Alphonse Crespo founder and executive director of Medicine and Liberty. Swiss orthopedic surgeon, author of Esculape Foudroyé (Les Belles Lettres 1991), ISBN 2-251-39008-1 and of numerous essays and articles such as Black Market Medicine an Ethical alternative to State Control, Outlawing Medicine or The End of Welfare and its effect on the Poor. President of the Cercle de philosophie politique Benjamin Constant at the Institut Libéral a Swiss think tank founded in 1979. Also conducts Med-Consilium a Swiss accident insurance consulting & assessment independent service.
Serban Sichitiu
Reputed paediatrician practicing in Lausanne. He was one of the founders of Switzerland's Patient and Physician Union active in the defense of patient and phyisician rights and liberties.
Medicine & Liberty
Sentier de la Tour-Carrée 9
CH-1800 Vevey - Switzerland
Tel & fax: 41 21 922 60 82
info@medlib.ch
Articles
PUBLICATIONS
from Medicine & Liberty and other sources
Free To Choose Medicine in Japan
July 18, 2018
Heartland Insistute's June 2018 Polciy Brief, offers readers an update on the impementation in Japan of Bart Madden's Free To Choose Medicine concept, a model for America and at the core of a campaign to reform the FDA.
The right to try new medicines
July 22, 2016
Bart Madden aptly puts forward his Free to Choose Medicine & Right to Try concept in an enlightening presentation that thoughfully summarizes novative proposals designed to open patient accesss to innovation in respect of their fundamental rights.
What is our Mission
May 16, 2016
Melinda Woofter president of the Association of American Physicians and Surgeons (AAPS) reminds physicians of their essential mission and aptly singles out destructive facets of big brother governement regulation that threaten it.
Read the article in AAPSonline
Criminalizing Healthcare
March 12, 2013
Criminalizing Health Care, Old Scapegoats and New Targets
How regulation treats health care professionals and Pharmaceutical industries as criminals until proved innocent.
Regulation, Cartels, Quality & Choice : an Unsustainable Swiss Mix
March 18, 2012
Swiss social security rests on private initiative, employer mandates and government subsidy. Its original design allowed substantial room for individual responsibility and competition while limiting government to the tasks of safeguarding public health and guaranteeing basic provision for disability and age. (...) Compared to other systems, Swiss health care still rates well and some of its specificities do indeed deserve praise. However lessons can be learned from the circumstances that brought quality downgrades and restriction of choice into what was once an almost perfect health care system.
*Original English version of "Regolamentazione, cartelli, qualità e scelta: un mix svizero insostenibile" published by Bruno Leoni Institute 2010 in "Eppur si muove" (ISBN 978-88-6440-0818-1)
Getting Rid of Marx and Bismarck in healthcare: the German quagmire.
November 14, 2011
Post-war Germany lived with both Bismarckian and Marxist models of socialized health care. With the fall of the Berlin Wall, East Germans dispatched Marxism into the dustbin of history and embraced market capitalism and the free world. The social insurance system offered by reunited Germany however, still owes more to ghosts of the old Prussian order than to the free market.
If Government Control is so Great, Why Are German Physicians so Unhappy?
June 10, 2011
Comparative effectiveness research is a bureaucratic gimmick that strikes at physician professional autonomy. It has significantly hurt physician motivation in Germany. It will do the same wherever it is implemented. It also lays the ground for conflict between modern precision medicine - that moves physicians towards genetically guided personalized treatment - and centralized administrative assessments of “effectiveness” grounded on volatile statistical estimates that blur individual patient characteristics.
What “Comparative Effectiveness Research” Means to You
December 13, 2010
A billion dollar parasite posing as "comparative effectiveness" is ready to infest US health care while allowing pseudo-researchers to thrive on tax-booties and giving true bureaucrats more tools for rationing.
Read the Article in AAPS online
Electronic Medical Records in the Age of Wikileaks
December 6, 2010
Can government keep your personal medical information private? ObamaCare is offering every physician $44,000 in taxpayer dollars to set up a new electronic medical record system: a promising source of MediLeaks.
What We Can Learn From a Canadian Physician About Obamacare
October 12, 2010
When Dr. Jacques Chaoulli decided to emigrate to the New World in 1979, he opted for Canada, rather than the United States. He wanted to live in the country that seemed more compassionate. He ended up investing his courage and energy in a formidable legal battle to change the rationed Canadian health system he discovered.
Dr Chaoulli in Salt Lake City (with A. Crespo)
Health Care Reform in the Netherlands
June 14, 2010
The Molinari Economic Institute released a paper by Valentin Petchkantin on the positive effects of Dutch health care reform. The dutch moved from a heavily socialized system to more market and choice.
Fraud, Waste and Abuse
May 18, 2010
Dr. Watson, President of the Association of American Physicians & Surgeons and former Air Force officer uncovers the sleazy underside of Obamacare.
Read his article in AAPS online
Should healthcare be a human right?
January 5, 2010
In this new release from IPN, Jacob Mchangama, Danish human rights academic, questions Government's provision of health and demonstrates that by hurting general prosperity through its intrusions, Government basically undermines access to appropriate health care.
The Morality of Obamacare
October 11, 2009
Obama equates compulsory health insurance with "a core moral obligation". Compelling citizen A to pay provider B for care of patient C by taxes or premiums, is not the same thing as “looking out for one another.” It invariably kills altruism as is demonstrated wherever and whenever such a model is instituted (Read "The end of welfare and the poor"). Government coercion is not moral: it ultimately leads either to slavery or to strife.
Health Care's Swiss Solution
October 5, 2009
Switzerland is seen as a possible model for US healthcare reform. Though the Swiss have avoided some pitfalls of Bismarckian systems, they have yet to check the power of cartels spawned by mandatory insurance. An all American solution based on Catastrophic Health Insurance, Health Savings Accounts, tax credits and carefully targeted subsidies would show the world how healthcare can flourish.
Political Malpractice: Health Insurance Misdiagnosis and the Destruction of Medical Wealth
September 11, 2009
In this in depth Issue Paper from the Competitve Entreprise Institute, Gregory Conko and Philip Klein analyse the specificities of third party purchase of health insurance and government regulated medical care and demonstrate how an insufficient undertanding of their effects on costs can significantly damage health care.
Paying for le Treatment
August 30, 2009
Guy Sorman reminds us that there is no such thing as "public, reliable and free" and that this applies to French health care as it would to any Government funded or controlled service.
Source: Nicomaque
“Illusions of Cost Control in Public Health Care Plans,
August 9, 2009
The claims that the bargaining power of public health plan managers can bring costs down fails to take into account the influence of special interest groups and cartels. This is but one of the many flaws of government driven "cost-containment" that Dr Book's thorough analysis exposes with hard numbers at hand.
Source: Heritage Foundation Research,
Note: Similar illusions brought the Swiss to vote in 1994 for mandatory insurance and for stronger regulatory powers to federal public health offices. The Swiss insurer's cartel won the lobbying war of influence that folowed and now dictates cost-containment policies that punish doctors and patients while getting away with substantial insurance premium hikes year after year.
Health Insurance & Collectivism
August 7, 2009
In *Machan's Inputs" philosopher Tibor Machan reflects on the collectivist essence of social-democratic health reforms & on the loss of fundamental liberties that they imply
Health Insurance and Bankruptcy Rates in Canada and the United States
July 9, 2009
Downgrading American Medical Care
June 12, 2009
Patient advocate and former Lt. Governor of New York State, Betsy McCaughey PhD, joins the growing number of whistle blowers who have anticipated what President Obama's haste for health reform at all costs could ultimately cost to American citizens in general and to suffering patients in particular.
Source: The American Spectator
How to Stop Socialized Health Care
June 11, 2009
America bowed to socialized health care once: with Medicare and Medicaid. Democrats want to take American patients and taxpayers one step further down the slippery road that leads to bureaucratic medicine and rationed care. In a thoughful WSJ op-ed, Karl Rove demonstrates that America does not need a European-style welfare state and shows why socialized health care can't work there.
Source: The Wall Street Journal
Headaches Come with Heidi-care
May 1, 2009
"The Obama administration plans to create a $634 billion fund to expand healthcare coverage in the U.S. It seems as reforms will have a European flavor, drawing inspiration from countries that have adopted compulsory insurance like Switzerland."
In an op-ed pubished by the Chicago Tribune Alphonse Crespo takes a surgeon's look at Swiss health care and suggests that Americans think twice before adopting this model.
COMPARATIVE EFFECTIVENESS: Refining the Standards for FDA Approval & CMS Coverage
May 1, 2009
"Comparative effectiveness" (CE) is the latest tool designed to dress bureaucratic control of prescriptions and rationing in scientific garb. Conscientious academics such as Prof. Michael Schandler have described the methodological flaws that undermine CE data. It is now the turn of reputed lawyers such as Areta L. Kupchyk to recommend caution before using CE in FDA or Medicare/Medicaid centralized decision processes.
From the Washington Legal Foundation
The Decline of Social Insurance in Modern Healthcare
February 19, 2009
Lessons from Switzerland and beyond
A Clockwork Model that Fails to Keep Promises
February 19, 2009
Swiss care ripe for change: assessing promises and problems
The Morality of Medical Black Markets
February 19, 2009
Black is in the eye of the beholder
Healthcare: State Failure
January 18, 2009
The Institute of Economic Affairs publishes a timely update on the consequences of state intrusion in healthcare including an article from Pierre Bessard, Member of our MedECON Academic board.
DIALOGUE WITH NOBEL LAUREATE VERNON SMITH
November 7, 2008
In an exclusive dialogue with Alphonse Crespo, Nobel Laureate Vernon Smith, explains how experimental economics open new institutional pathways for patient choice and medical innovation.
Black Market Medicine: an Ethical Alternative to State Control
September 1, 2008
A classic on ethics vs. state morality in medical care
WHO promotes obsolete statist myths
September 1, 2008
International bureaucrats still believe that only massive government intervention can end disease and poverty. Philip Stevens comments WHO's doctrinary report on the "social deteminants of health" in the South China Morning Post
Privatization of health care in Canada?
August 31, 2008
I love you, neither do I: Canadian health care music sung by Pierre Lemieux in his Liberty in Canada chronicle
Trouble in the Ranks
May 25, 2008
A study published by Campaign for Fighting Diseases shows how WHO’s health system rankings are biased towards taxpayer-funded systems.
Outlawing Medicine
January 1, 2008
Despite global privatization of state industries and services that followed the Thatcher revolution, bureaucratic regulation of Medicine is still largely accepted as the norm and state control of health care has never ceased to grow...
En Defensa del Derecho de Informacion al Paciente
July 10, 2007
Published by the Instituto Juan de Mariana a paper that highlights freedom of information (in Spanish)
Lessons From Europe and Canada
2007
The dangers of undermining patient choice highlighted by a study published by the Institute for Policy Innovation and the Galen Institute
The Old, the Ailing & the State
2009
How modern social security perverts medical ethics and corrupts the philosophy of welfare
The Hazards Of Harassing Doctors
2009
A disquieting essay on the rising rumble of doctor protest and revolt in Europe, published by CMPI NY
Local Pharmaceutical Production in Developing Countries
2008
How protectionism hinders care and cure in developing nations
The Myth of a General AIDS Pandemic
2008
How billions are wasted on unnecessary AIDS prevention programmes. A discussion paper published by Campaign for Fighting Diseases
Foreign Aid for Health
2008
How government to government aid for healthcare feeds parasites without improving health in populations. A study by Campaign for Fighting Diseases published in association with MedLib.CH.
The Truth about Drug Innovation
2008
Who really pays for drug innovation? A recent study from the Manhattan Institute's Center for Medical Progress & Tufts University scientists demonstrates the vital role of the private sector in this crucial field of therapeutic progress.
Canadian health care's dirty little secrets
2008
A new study from the Fraser Institute demonstrates that Canada's sovietized health care counts a proportion of uninsured population at least equivalent to that of the US. This paper confirms the cruel shortcomings of single payer health monopolies compared to pluralistic insurance models.
The landscape of patient information in Germany
2008
AAPS reminds us of fundamental principles that should guide medical policy
2008
In the wake of an impending overhaul of America's healthcare system, the Journal of American Physicians and Surgeons (JAPandS) aptly reminds policy makers of essential principes that underly human medical services.
Why a New Public Plan Will Not Improve American Health Care
2009
"Why should Americans believe that after 40 lethargic years the Medicare program, as run by Congress, will be transformed into an innovative, nimble program that can reform health care and reduce waste and overuse of health care services?"
Walton Francis, economist and policy analyst tackles this crucial question in a backgrounder for Heritage Foundation.
When Doctors Opt Out!
2009
"Health insurance doesn't automatically lead to health care." Dr Marc Siegel reminds us that medicine cannot work without physicians in a timely article published by the Wall Street Journal
Wrong answers to high drug prices
2009
Rationing of new therapeutic products on grounds of price not only reflects health policy makers' insensitivity to human suffering, it is also a sign of poor economics. Cure ultimately costs less than disease and innovation is a long term investment. Philip Steven's article on government mishandling of health care provision and of drug approval processes explains how.
Source: The Fraser Institute
Cost of Canadian waiting lists tops $750 million
2008
Canadians pay a heavy price for their rationing of medical care by the queue. Not only in terms of human suffering (though that is irrelevant for health policy makers) but also in loss of productivity. In 2008, an estimated 750,794 Canadians were waiting for treatment after an appointment with a specialist.
The Fraser Institute calculates that queues cost Canadians more than $750 million in 2008. As the AAPS highlights in News of the day: the public system saves less thant what it wastes by restricting access to medical care and private persons pay the cost.
What does the “stimulus bill” mean for medicine?
2009
This will unfortunately impact on American medicine as AAPS's predicts in News of the Day
